ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

ADTX Aditxt Inc

2.30
-0.17 (-6.88%)
04 May 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type
Aditxt Inc NASDAQ:ADTX NASDAQ Common Stock
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -0.17 -6.88% 2.30 2.29 2.60 2.40 2.28 2.37 44,596 00:49:27

Small Company Offering and Sale of Securities Without Registration (d)

26/01/2021 3:46pm

Edgar (US Regulatory)


o NoneEntity Type
0001726711
ADiTx Therapeutics, Inc.
 
x Corporation
o Limited Partnership
o Limited Liability Company
o General Partnership
o Business Trust
o Other
Name of Issuer
 Aditx Therapeutics, Inc.
Jurisdiction of Incorporation/OrganizationDELAWARE 
Year of Incorporation/Organization
  o Over Five Years Ago
  x Within Last Five Years (Specify Year) 2017
  o Yet to Be Formed 



2. Principal Place of Business and Contact Information
Name of Issuer 
 Aditx Therapeutics, Inc. 
Street Address 1Street Address 2
 2569 WYANDOTTE ST. SUITE 101
CityState/Province/CountryZIP/Postal CodePhone No. of Issuer
 MOUNTAIN VIEW CALIFORNIA 94043 909-488-0844 



3. Related Persons
Last NameFirst NameMiddle Name
AlbannaAmro
Street Address 1Street Address 2
2569 Wyandotte St.Suite 101
CityState/Province/CountryZIP/Postal Code
Mountain ViewCALIFORNIA94043
Relationship: x Executive Officer x Director o Promoter
Clarification of Response (if Necessary)
 Chief Executive Officer

Last NameFirst NameMiddle Name
ShabahangShahrokh
Street Address 1Street Address 2
2569 Wyandotte St.Suite 101
CityState/Province/CountryZIP/Postal Code
Mountain ViewCALIFORNIA94043
Relationship: x Executive Officer x Director o Promoter
Clarification of Response (if Necessary)
 Chief Innovation Officer

Last NameFirst NameMiddle Name
PankovcinCorinne
Street Address 1Street Address 2
2569 Wyandotte St.Suite 101
CityState/Province/CountryZIP/Postal Code
Mountain ViewCALIFORNIA94043
Relationship: x Executive Officer o Director o Promoter
Clarification of Response (if Necessary)
 Chief Financial Officer and Secretary

Last NameFirst NameMiddle Name
AlbannaRowena
Street Address 1Street Address 2
2569 Wyandotte St.Suite 101
CityState/Province/CountryZIP/Postal Code
Mountain ViewCALIFORNIA94043
Relationship: x Executive Officer o Director o Promoter
Clarification of Response (if Necessary)
 Chief Operating Officer

 
Last NameFirst NameMiddle Name
AnthonyLauraE.
Street Address 1Street Address 2
2569 Wyandotte St.Suite 101
CityState/Province/CountryZIP/Postal Code
Mountain ViewCALIFORNIA94043
Relationship: o Executive Officer x Director o Promoter
Clarification of Response (if Necessary)
 

Last NameFirst NameMiddle Name
BradyBrian
Street Address 1Street Address 2
2569 Wyandotte St.Suite 101
CityState/Province/CountryZIP/Postal Code
Mountain ViewCALIFORNIA94043
Relationship: o Executive Officer x Director o Promoter
Clarification of Response (if Necessary)
 

Last NameFirst NameMiddle Name
KiaieNamvar
Street Address 1Street Address 2
2569 Wyandotte St.Suite 101
CityState/Province/CountryZIP/Postal Code
Mountain ViewCALIFORNIA94043
Relationship: o Executive Officer x Director o Promoter
Clarification of Response (if Necessary)
 

Last NameFirst NameMiddle Name
RungeJeffreyW.
Street Address 1Street Address 2
2569 Wyandotte St.Suite 101
CityState/Province/CountryZIP/Postal Code
Mountain ViewCALIFORNIA94043
Relationship: o Executive Officer x Director o Promoter
Clarification of Response (if Necessary)
 

 


4. Industry Group
o Agriculture Health Care o Retailing
 Banking & Financial Services   x Biotechnology o Restaurants
  o Commercial Banking   o Health Insurance Technology
  o Insurance  o Hospitals & Physicians  o Computers
  o Investing  o Pharmaceuticals  o Telecommunications
  o Investment Banking  o Other Health Care  o Other Technology
  o Pooled Investment Fund

    Travel
  o Other Banking & Financial Services o Manufacturing  o Airlines & Airports
 Real Estate  o Lodging & Conventions
  o Commercial  o Tourism & Travel Services
  o Construction  o Other Travel
  o REITS & Finance o Other
  o Residential 
  o Other Real Estate 
o Business Services 
 Energy 
  o Coal Mining 
  o Electric Utilities 
  o Energy Conservation 
  o Environmental Services 
  o Oil & Gas 
  o Other Energy 


5. Issuer Size
Revenue RangeAggregate Net Asset Value Range
o No Revenues o No Aggregate Net Asset Value
o $1 - $1,000,000 o $1 - $5,000,000
o $1,000,001 - $5,000,000 o $5,000,001 - $25,000,000
o $5,000,001 - $25,000,000 o $25,000,001 - $50,000,000
o $25,000,001 - $100,000,000 o $50,000,001 - $100,000,000
o Over $100,000,000 o Over $100,000,000
x Decline to Disclose o Decline to Disclose
o Not Applicable o Not Applicable


6. Federal Exemption(s) and Exclusion(s) Claimed (select all that apply)
o Rule 504(b)(1) (not (i), (ii) or (iii)) o Rule 505
o Rule 504 (b)(1)(i) x Rule 506(b)
o Rule 504 (b)(1)(ii) o Rule 506(c)
o Rule 504 (b)(1)(iii) o Securities Act Section 4(a)(5)
  o Investment Company Act Section 3(c)

7. Type of Filing
x New Notice Date of First Sale 2021-01-25 o First Sale Yet to Occur
o Amendment

8. Duration of Offering
Does the Issuer intend this offering to last more than one year? o Yes x No

9. Type(s) of Securities Offered (select all that apply)
o Pooled Investment Fund Interests o Equity
o Tenant-in-Common Securities x Debt
o Mineral Property Securities x Option, Warrant or Other Right to Acquire Another Security
x Security to be Acquired Upon Exercise of Option, Warrant or Other Right to Acquire Security x Other (describe)
 Senior Secured Convertible Promissory Note


10. Business Combination Transaction
Is this offering being made in connection with a business combination transaction, such as a merger, acquisition or exchange offer? o Yes x No
 
Clarification of Response (if Necessary) 
  

11. Minimum Investment
Minimum investment accepted from any outside investor$ 0 USD

12. Sales Compensation
RecipientRecipient CRD Number o None
 Dawson James Securities, Inc. 130645
(Associated) Broker or Dealer x None(Associated) Broker or Dealer CRD Number x None
    
Street Address 1Street Address 2
 101 NORTH FEDERAL HIGHWAY SUITE 600
City State/Province/CountryZIP/Postal Code
 BOCA RATON FLORIDA 33432
State(s) of Solicitation x All States o Foreign/Non-US
 

 



13. Offering and Sales Amounts
Total Offering Amount $ 6000000 USD o Indefinite
Total Amount Sold $ 6000000 USD 
Total Remaining to be Sold $ 0 USD o Indefinite
 
Clarification of Response (if Necessary)
  


14. Investors
o Select if securities in the offering have been or may be sold to persons who do not qualify as accredited investors,
Number of such non-accredited investors who already have invested in the offering
 
  Regardless of whether securities in the offering have been or may be sold to persons who do not qualify as accredited investors, enter the total number of investors who already have invested in the offering: 1


15. Sales Commissions & Finders’ Fees Expenses
Provide separately the amounts of sales commissions and finders' fees expenses, if any. If the amount of an expenditure is not known, provide an estimate and check the box next to the amount.
Sales Commissions$ 380000 USD o Estimate
Finders' Fees$ 0 USD o Estimate
 
Clarification of Response (if Necessary)
  


16. Use of Proceeds
Provide the amount of the gross proceeds of the offering that has been or is proposed to be used for payments to any of the persons required to be named as executive officers, directors or promoters in response to Item 3 above. If the amount is unknown, provide an estimate and check the box next to the amount.
 $ 0 USD o

1 Year Aditxt Chart

1 Year Aditxt Chart

1 Month Aditxt Chart

1 Month Aditxt Chart

Your Recent History

Delayed Upgrade Clock